154 related articles for article (PubMed ID: 10754525)
21. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
[TBL] [Abstract][Full Text] [Related]
22. Loss of FHIT expression in gastric carcinoma.
Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
[TBL] [Abstract][Full Text] [Related]
23. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
[TBL] [Abstract][Full Text] [Related]
24. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas.
Ferrer M; López-Borges S; Lazo PA
Mol Carcinog; 1999 May; 25(1):55-63. PubMed ID: 10331745
[TBL] [Abstract][Full Text] [Related]
25. fhit Alterations in endometrial carcinoma and hyperplasia.
Ozaki K; Enomoto T; Yoshino K; Hongbo S; Nakamura T; Fujita M; Kuragaki C; Sakata M; Kurachi H; Murata Y
Int J Cancer; 2000 Feb; 85(3):306-12. PubMed ID: 10652418
[TBL] [Abstract][Full Text] [Related]
26. [Alteration of FHIT gene and p16 gene in malignant transformed cells induced by crystalline nickel sulfide].
Ji WD; Wu ZL; Chen JK; Yi F; Feng SM
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):26-30. PubMed ID: 12678982
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.
Luceri C; Guglielmi F; De Filippo C; Caderni G; Mini E; Biggeri A; Napoli C; Tonelli F; Cianchi F; Dolara P
Scand J Gastroenterol; 2000 Jun; 35(6):637-41. PubMed ID: 10912665
[TBL] [Abstract][Full Text] [Related]
28. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.
Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS
Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
30. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
[TBL] [Abstract][Full Text] [Related]
31. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells.
Ji WD; Chen JK; Lu JC; Wu ZL; Yi F; Feng SM
Biomed Environ Sci; 2006 Aug; 19(4):277-84. PubMed ID: 17044645
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression and deletion of FHIT gene in leukemias.
Wang L; Dong LJ; Tian F; Liu GX; Li CH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737
[TBL] [Abstract][Full Text] [Related]
34. Structure and expression of the human FHIT gene in normal and tumor cells.
Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K
Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482
[TBL] [Abstract][Full Text] [Related]
35. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
[TBL] [Abstract][Full Text] [Related]
36. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
37. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
Hendricks DT; Taylor R; Reed M; Birrer MJ
Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105
[TBL] [Abstract][Full Text] [Related]
38. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM
Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101
[TBL] [Abstract][Full Text] [Related]
39. Aberrant FHIT expression is linked to bladder carcinogenesis and apoptosis.
Han Y; Zhang Z; Zhang GJ; Guo KF; Shan GY; Kong CZ
Asian Pac J Cancer Prev; 2011; 12(11):2915-20. PubMed ID: 22393963
[TBL] [Abstract][Full Text] [Related]
40. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
